PARP inhibitors in first-line of ovarian cancers

被引：0
|
作者：
Rodrigues, Manuel [1 ,2 ]
机构：
[1] DRUM, Equipe Labellisee Ligue Natl Canc, Inserm, U830, Paris, France
[2] PSL Res Univ, Inst Curie, Dept Oncol Med, Paris, France
来源：
BULLETIN DU CANCER | 2020年 / 107卷 / 01期
关键词：
D O I：
10.1016/j.bulcan.2019.10.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4 / 5
页数：2
相关论文
共 50 条
  • [1] PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts?
    Franzese, Elisena
    Diana, Anna
    Centonze, Sara
    Pignata, Sandro
    De Vita, Ferdinando
    Ciardiello, Fortunato
    Orditura, Michele
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [2] Subsequent management and outcomes after first-line PARP inhibitors progression in ovarian cancer patients
    Yuan, Hua
    Li, Ning
    Wu, Lingying
    Yao, Hongwen
    [J]. JOURNAL OF OVARIAN RESEARCH, 2024, 17 (01)
  • [3] Subsequent management and outcomes after first-line PARP inhibitors progression in ovarian cancer patients
    Hua Yuan
    Ning Li
    Lingying Wu
    Hongwen Yao
    [J]. Journal of Ovarian Research, 17
  • [4] Treatment Considerations for PARP Inhibitors in First-Line Maintenance Therapy in Patients With Advanced Ovarian Cancer
    Previs, Rebecca
    [J]. ONCOLOGY-NEW YORK, 2021, 35 (04): : 224 - 227
  • [5] PARP Inhibitors in Ovarian and Other Cancers
    Plummer, Ruth
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (05) : 283 - 285
  • [6] PARP inhibitors for all ovarian cancers
    Javier Carmona
    [J]. Nature Medicine, 2019, 25 : 1647 - 1647
  • [7] First-line PARP inhibition in ovarian cancer — standard of care for all?
    Susana N. Banerjee
    Christopher J. Lord
    [J]. Nature Reviews Clinical Oncology, 2020, 17 : 136 - 137
  • [8] First-line PARP inhibition in ovarian cancer - standard of care for all?
    Banerjee, Susana N.
    Lord, Christopher J.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (03) : 136 - 137
  • [9] PARP inhibitors and immunotherapy in ovarian and endometrial cancers
    Miller, Rowan E.
    Lewis, Amy J.
    Powell, Melanie E.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1128):
  • [10] First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
    Banerjee, Susana
    Gonzalez-Martin, Antonio
    Harter, Philipp
    Lorusso, Domenica
    Moore, Kathleen N.
    Oaknin, Ana
    Ray-Coquard, Isabelle
    [J]. ESMO OPEN, 2020, 5 (06)
12345